Toggle navigation
Home
Search
Services
Blog
Contact
About
Polymeric Platinum Complexes as Anicancer Prodrugs
Devinder, Gill
Andrulis Research Corporation, Bethesda, MD, United States
Search 7 grants from Gill Devinder
Search grants from Andrulis Research Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Children's Treatment and Recovery Center
Randomonized controlled trial-lactoferrin prevention of diarrhea in children
Saturated fatty acid-induced macrophage migration: role of toll-like receptor 4
Molecular Basis of Enterocyte Regulation During Ontogeny
Fear and the Anxiety Disorders: Brain and Behavior
Recently added grants:
Investigating the Regulation and Role of FOXM1 in Aggressive Meningioma
Effect of APOBEC3 on Bladder Cancer Biology and Response to Immunotherapy
Effect of Cyclical Intermittent Hypoxia on Lung Cancer Progression
Exploring the role of mitochondrial homeostatic processes in the accumulation and transmission of environmentally-induced mtDNA mutations across generations
Novel Diagnostics to Improve Antimicrobial Stewardship for Acute Respiratory Tract Infections in Resource-Limited Settings
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43CM057818-001
Application #
3613433
Study Section
Project Start
1985-09-30
Project End
Budget Start
1986-03-27
Budget End
1986-05-30
Support Year
Fiscal Year
1986
Total Cost
Indirect Cost
Institution
Name
Andrulis Research Corporation
Department
Type
DUNS #
City
Bethesda
State
MD
Country
United States
Zip Code
20814
Related projects
NIH 1986
N43 CM
Polymeric Platinum Complexes as Anicancer Prodrugs
Devinder, Gill / Andrulis Research Corporation
NIH 1985
N43 CM
Polymeric Platinum Complexes as Anicancer Prodrugs
Devinder, Gill / Andrulis Research Corporation
Comments
Be the first to comment on Gill Devinder's grant